Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome produces cuts

.After rearing $213 million in 2023-- some of the year's largest exclusive biotech shots-- Volume Bi...

BioMarin builds director crew along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Biopharma Q2 VC attacked highest level since '22, while M&ampA slowed down

.Venture capital financing in to biopharma cheered $9.2 billion throughout 215 sell the 2nd fourth o...

Bicara, Zenas look for IPOs to press late-phase possessions towards market

.Bicara Therapeutics and Zenas Biopharma have given new catalyst to the IPO market along with filing...

Genentech to shut cancer cells immunology analysis division

.Genentech will shut its cancer cells immunology analysis team, and unit head and distinguished cell...

Kezar falls sound tumor yet to confirm its own truly worth in period 1 trial

.Kezar Life Sciences is actually losing its own unpromising stage 1 solid tumor medicine as the biot...

Acelyrin loses izokibep, dismisses 3rd of personnel

.Despite izokibep preserving its own newly found winning streak in the facility, Acelyrin is no more...

Rivus' period 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing medicatio...

Ovid stops preclinical job, IV course after soticlestat fail

.Ovid Therapy actually disclosed final month that it was actually trimming its own headcount as the ...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston ma Seaport, improving its ...